Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
PRC2 Restricts Malignant Peripheral Nerve Sheath Tumorigenesis in a Genetically Engineered Mouse Model of MPNST.
Journal: bioRxiv : the preprint server for biology
Published: November 26, 2025
TAD hierarchy restricts poised LTR activation and loss of TAD hierarchy promotes LTR co-option in cancer.
Journal: bioRxiv : the preprint server for biology
Published: June 19, 2024
MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 06, 2024
Disruption of TAD hierarchy promotes LTR co-option in cancer.
Journal: Nature genetics
Published: May 02, 2023
Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets.
Journal: Science (New York, N.Y.)
Published: May 26, 2022
Phase II Trial of Imatinib Plus Binimetinib in Patients With Treatment-Naive Advanced Gastrointestinal Stromal Tumor.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 18, 2022
Phase Ib Trial of the Combination of Imatinib and Binimetinib in Patients with Advanced Gastrointestinal Stromal Tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 02, 2021
Tumor-intrinsic PRC2 inactivation drives a context-dependent immune-desert microenvironment and is sensitized by immunogenic viruses.
Journal: The Journal of clinical investigation
Published: July 22, 2021
Showing 1-11 of 11
Last Updated: 09/26/2026